- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 165968, 6 pages
Royal Jelly Facilitates Restoration of the Cognitive Ability in Trimethyltin-Intoxicated Mice
1Nagaragawa Research Center, API Co., Ltd, Nagara, Gifu 502-0071, Japan
2Laboratory of Molecular Biology, Gifu Pharmaceutical University, Daigaku-nishi 1-25-4, Gifu 501-1196, Japan
Received 5 July 2008; Accepted 16 March 2009
Copyright © 2011 Noriko Hattori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. Izuta, Y. Chikaraishi, M. Shimazawa, S. Mishima, and H. Hara, “10-hydroxy-2-decenoic acid, a major fatty acid from RJ, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells,” in Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 4, pp. 489–494, 2009.
- T. Takenaka, “Chemical compositions of royal jelly,” Honeybee Science, vol. 3, pp. 69–74, 1982.
- T. Echigo, T. Takenaka, and K. Yatsunami, “Comparative studies on chemical composition of honey, royal jelly and pollen loads,” Bulletin of the Faculty of Agriculture Tamagawa University, vol. 26, pp. 1–12, 1986.
- A. Fujii, S. Kobayashi, and S. Kobayashi, “Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats,” Japanese Journal of Pharmacology, vol. 53, no. 3, pp. 331–337, 1990.
- H. Oka, Y. Emori, N. Kobayashi, Y. Hayashi, and K. Nomoto, “Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses,” International Immunopharmacology, vol. 1, no. 3, pp. 521–532, 2001.
- L. Šver, N. Oršolić, Z. Tadić, B. Njari, I. Valpotić, and I. Bašić, “A royal jelly as a new potential immunomodulator in rats and mice,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 19, no. 1, pp. 31–38, 1996.
- Y. Taniguchi, K. Kohno, and K. Kohno, “Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice,” International Immunopharmacology, vol. 3, no. 9, pp. 1313–1324, 2003.
- N. Hattori, H. Nomoto, S. Mishima, S. Inagaki, M. Goto, M. Sako, and S. Furukawa, “Identification of AMP -oxide in royal jelly as a component neurotrophic toward cultured rat pheochromocytoma PC12 cells,” Bioscience, Biotechnology and Biochemistry, vol. 70, no. 4, pp. 897–906, 2006.
- N. Hattori, H. Nomoto, H. Fukumitsu, S. Mishima, and S. Furukawa, “Royal jelly-induced neurite outgrowth from rat pheochromocytoma PC12 cells requires integrin signal independent of activation of extracellular signal-regulated kinases,” Biomedical Research, vol. 28, no. 3, pp. 139–146, 2007.
- N. Hattori, H. Nomoto, H. Fukumitsu, S. Mishima, and S. Furukawa, “Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro,” Biomedical Research, vol. 28, no. 5, pp. 261–266, 2007.
- N. Hattori, H. Nomoto, H. Fukumitsu, S. Mishima, and S. Furukawa, “AMP -oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase,” in Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 1, pp. 63–68, 2010.
- T. Abel, P. V. Nguyen, M. Barad, T. A. S. Deuel, E. R. Kandel, and R. Bourtchouladze, “Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory,” Cell, vol. 88, no. 5, pp. 615–626, 1997.
- U. Frey, Y.-Y. Huang, and E. R. Kandel, “Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons,” Science, vol. 260, no. 5114, pp. 1661–1664, 1993.
- A. Fiedorowicz, I. Figiel, B. Kamińska, M. Zaremba, S. Wilk, and B. Oderfeld-Nowak, “Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure,” Brain Research, vol. 912, no. 2, pp. 116–127, 2001.
- K. Ogita, Y. Nitta, M. Watanabe, Y. Nakatani, N. Nishiyama, C. Sugiyama, and Y. Yoneda, “In vivo activation of c-Jun N-terminal kinase signaling cascade prior to granule cell death induced by trimethyltin in the dentate gyrus of mice,” Neuropharmacology, vol. 47, no. 4, pp. 619–630, 2004.
- K. Ogita, N. Nishiyama, C. Sugiyama, K. Higuchi, M. Yoneyama, and Y. Yoneda, “Regeneration of granule neurons after lesioning of hippocampal dentate gyrus: evaluation using adult mice treated with trimethyltin chloride as a model,” Journal of Neuroscience Research, vol. 82, pp. 609–621, 2005.
- M. Niittykoski, R. Lappalainen, J. Jolkkonen, A. Haapalinna, P. Riekkinen Sr., and J. Sirvio, “Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats,” Neuroscience & Biobehavioral Reviews, vol. 22, pp. 735–750, 1998.
- N. Ishida, M. Akaike, S. Tsutsumi, et al., “Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment,” Neuroscience, vol. 81, pp. 1183–1191, 1997.
- K. Yamada, T. Tanaka, L. B. Zou, et al., “Long-term deprivation of estrogens by ovariectomy potentiates beta-amyloyd-induced working memory deficits in rats,” British Journal of Pharmacology, vol. 128, pp. 419–427, 1999.
- F. H. Gage, “Mammalian neural stem cells,” Science, vol. 287, no. 5457, pp. 1433–1438, 2000.
- C. M. Morshead, C. G. Craig, and D. Van der Kooy, “In vivo clonal analyses reveal the properties of endogenous neural stem cell proliferation in the adult mammalian forebrain,” Development, vol. 125, no. 12, pp. 2251–2261, 1998.
- C. Lois and A. Alvarez-Buylla, “Long-distance neuronal migration in the adult mammalian brain,” Science, vol. 264, no. 5162, pp. 1145–1148, 1994.
- M. B. Luskin, “Neuronal cell lineage in the vertebrate central nervous system,” FASEB Journal, vol. 8, no. 10, pp. 722–730, 1994.
- E. Gould, P. Tanapat, N. B. Hastings, and T. J. Shors, “Neurogenesis in adulthood: a possible role in learning,” Trends in Cognitive Sciences, vol. 3, pp. 186–192, 1999.
- N. Hattori, H. Nomoto, H. Fukumitsu, S. Mishima, and S. Furukawa, “AMP -oxide potentiates astrogenesis by cultured neural stem/progenitor cells through STAT3 activation,” Biomedical Research, vol. 28, no. 6, pp. 295–299, 2007.
- D. T. Balu and I. Lucki, “Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology,” Neuroscience and Biobehavioral Reviews, vol. 33, no. 3, pp. 232–252, 2009.